title: Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
authors: aResearch Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen University Hospital, Roskilde bDepartment of Cardiology, Gentofte University Hospital, Hellerup, Denmark.
authors: Ditte
authors: D
authors: Bjerre
authors: Laura
authors: L
authors: Ferrero
authors: Majbritt
authors: M
authors: Madsen
authors: Peter R
authors: PR
authors: Hansen
authors: Henrik B
authors: HB
authors: Rasmussen
mesh_terms: D002265:Carboxylic Ester Hydrolases / Q000235:genetics*; D003327:Coronary Disease / Q000628:therapy*; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D065731:Cytochrome P-450 CYP2C19; D002265:Carboxylic Ester Hydrolases; D013988:Ticlopidine